Intervention

triptorelin

ClinicalTrials.gov intervention label

Clinical trials15

Recruiting0

Common conditions13

Lead sponsors shown11

Clinical trials

15 shown

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandNCT05701007 · 2023-02-13

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerNCT02278185 · 2015-11-11

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)NCT02742675 · 2015-09-01

TRial on the Endocrine Activity of Neoadjuvant DegarelixNCT02005887 · 2014-02-01

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate CancerNCT02238366 · 2013-11-01

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate CancerNCT00667069 · 2008-04-07

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02NCT00659373 · 2007-12-01

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast CancerNCT00090844 · 2004-07-01

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.NCT00412022 · 2004-03-01

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerNCT00104741 · 2003-09-10

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryNCT00311636 · 2003-09-01

Premenopausal Endocrine Responsive Chemotherapy TrialNCT00066807 · 2003-08-01

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate CancerNCT00003734 · 1998-12-01

Hormone Therapy in Treating Patients With Advanced Prostate CancerNCT00003026 · 1997-04-01

Common conditions

Breast Cancer6 Prostate Cancer6 Adenocarcinoma of the Prostate1 Breast Cancer Invasive Nos1 Drug Toxicity1 Fatigue1 Hormone Changes1 Metastatic Castration Resistant Prostate Cancer (mCRPC)1 Metastatic Castration Sensitive Prostate Cancer (mCSPC)1 Recurrent Prostate Cancer1 Sleep Disorders1 Stage III Prostate Cancer1 Stage IV Prostate Cancer1

Leading sponsors

ETOP IBCSG Partners Foundation4 UNICANCER2 European Organisation for Research and Treatment of Cancer - EORTC1 Fudan University1 Gruppo Italiano Mammella (GIM)1 Ipsen1 National Cancer Institute, Naples1 Pfizer1 St. Luke's Hospital, Ireland1 University of Colorado, Denver1 University of South Florida1

Trial status mix

COMPLETED10

UNKNOWN3

TERMINATED2

Phase mix

PHASE39

PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.